Citigroup Inc Regenxbio Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Regenxbio Inc. stock. As of the latest transaction made, Citigroup Inc holds 95,511 shares of RGNX stock, worth $706,781. This represents 0.0% of its overall portfolio holdings.

Number of Shares

95,511

Previous 42,908 122.59%

Holding current value

$706,781

Previous $502,000 99.4%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$10.49 - $14.39 $551,805 - $756,957	52,603 Added 122.59%	95,511 $1 Million
Q2 2024 Aug 12, 2024	SELL	$11.51 - $21.53 $1.66 Million - $3.1 Million	-143,845 Reduced 77.02%	42,908 $502,000
Q1 2024 May 10, 2024	BUY	$12.17 - $24.61 $1.39 Million - $2.82 Million	114,542 Added 158.62%	186,753 $3.93 Million
Q4 2023 Feb 09, 2024	SELL	$12.89 - $20.82 $378,643 - $611,587	-29,375 Reduced 28.92%	72,211 $1.3 Million
Q3 2023 Nov 09, 2023	BUY	$16.46 - $19.99 $328,360 - $398,780	19,949 Added 24.44%	101,586 $1.67 Million
Q2 2023 Aug 10, 2023	SELL	$17.23 - $21.71 $727,622 - $916,813	-42,230 Reduced 34.09%	81,637 $1.63 Million
Q1 2023 May 11, 2023	BUY	$18.08 - $24.55 $630,196 - $855,714	34,856 Added 39.16%	123,867 $2.34 Million
Q4 2022 Feb 09, 2023	SELL	$20.4 - $24.73 $809,268 - $981,039	-39,670 Reduced 30.83%	89,011 $2.02 Million
Q3 2022 Nov 10, 2022	BUY	$22.29 - $35.04 $628,622 - $988,198	28,202 Added 28.07%	128,681 $3.4 Million
Q2 2022 Aug 10, 2022	BUY	$19.35 - $35.04 $756,120 - $1.37 Million	39,076 Added 63.64%	100,479 $2.48 Million
Q1 2022 May 12, 2022	SELL	$24.62 - $34.31 $1.68 Million - $2.34 Million	-68,195 Reduced 52.62%	61,403 $2.04 Million
Q4 2021 Feb 10, 2022	SELL	$30.19 - $40.28 $34,839 - $46,483	-1,154 Reduced 0.88%	129,598 $4.24 Million
Q3 2021 Nov 10, 2021	BUY	$29.09 - $45.68 $3.8 Million - $5.97 Million	130,752 New	130,752 $5.48 Million

Others Institutions Holding RGNX

# of Institutions

196

Shares Held

43M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $320M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account